Article
P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype.
Leukemia & lymphoma - 1 Jun 2002
Pallis Monica, Turzanski Julie, Higashi Yutaro, Russell Nigel
Abstract excerpt
P-glycoprotein (Pgp) expression is an independent prognostic factor for response to remission-induction chemotherapy in acute myeloblastic leukaemia, particularly in the elderly. There are several potential agents for modulating Pgp-mediated multi-drug resistance, such as cyclosporin A and PSC833, which are currently being evaluated in clinical trials. An alternative therapeutic strategy is to increase the use of...
Topics
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Acute Disease
- Adult
- Antineoplastic Agents
- Apoptosis
- Arsenic Trioxide
- Arsenicals
- Biological Transport
- Cell Division
- Ceramides
- Child
- Cyclosporine
- Cyclosporins
